Climb Bio, Inc. (CLYM)
11.73
+0.72
(+6.54%)
USD |
NASDAQ |
Nov 10, 16:00
11.73
0.00 (0.00%)
After-Hours: 20:00
Climb Bio Cash from Operations (Annual) : -54.36M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -54.36M |
| December 31, 2024 | -15.56M |
| December 31, 2023 | -20.60M |
| December 31, 2022 | -37.37M |
| Date | Value |
|---|---|
| December 31, 2021 | -36.07M |
| December 31, 2020 | -14.10M |
| December 31, 2019 | -5.008M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Korsana Biosciences, Inc. | -3.314M |
| Cullinan Therapeutics, Inc. | -175.75M |
| Q32 Bio, Inc. | -33.54M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |